Sale

Regional Analysis

Global Surrogacy Market Size, Share, Trends, Growth, Report: By Type: Gestational Surrogacy, Traditional Surrogacy; By Technology: IVF with ICSI, IVF without ICSI, Intrauterine Insemination, Others; By End User: Hospitals, IVF Centres, Others; Regional Analysis; Patent Analysis; Grants Analysis; Funding Analysis; Supplier Landscape; 2024-2032

Global Surrogacy Market Regional Analysis

Asia Pacific is expected to occupy a significant share of the market in the forecast period because surrogacy in developing nations like India is less expensive than in affluent countries like the United States and Canada, adding to this region's market growth. Furthermore, in the forecast period, the best technical outreach and inclination for surrogacy, particularly IVF kinds, is expected to further help in the surrogacy market growth.

 

In addition, due to the rising number of specialised clinics for assisted reproductive technologies, the surrogacy market in this area is expected to witness healthy growth. Hence, the region is expected to provide lucrative opportunities to the key players operating in the surrogacy market.

 

In June 2023, Beijing's government announced that it would cover 16 types of assisted reproduction technology under the city's health care system from July 1, the latest move by authorities to boost China's flagging birth rate. In-vitro fertilization, embryo transplantation, freezing, and storing semen are some of the treatments that would be included under basic insurance, said Du Xin, deputy director of Beijing's Municipal Medical Insurance Bureau.

 

This move was taken as China is facing a decline in birth rates. The number of newborns dropped to a record low of 6.77 per 1,000 people last year and is expected to decline further in 2023. Such initiatives may enable people to consider using procedures like IVF, IUI, and others to find a solution for their personal choices and infertility issues boosting the surrogacy market growth.

 

The initiative to cover 16 types of ART may increase access among people, the financial support is expected to boost the demand for such procedures including surrogacy, among people, propelling the market growth.

 

Surrogacy Market Report Snapshots

Surrogacy Market Size

Surrogacy Market Analysis

Surrogacy Companies

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
    1.1    Objectives of the Study
    1.2    Key Assumptions 
    1.3    Report Coverage – Key Segmentation and Scope  
    1.4    Research Methodology
2    Executive Summary
3    Global Surrogacy Market (2017-2032) Overview 

    3.1    Global Surrogacy Market Historical Value (2017-2023) 
    3.2    Global Surrogacy Market Forecast Value (2024-2032)
4    Global Surrogacy Market (2017-2032) Landscape*
    4.1    Global Surrogacy Developers Landscape
        4.1.1    Analysis by Year of Establishment
        4.1.2    Analysis by Company Size
        4.1.3    Analysis by Region
    4.2    Global Surrogacy Product Landscape
        4.2.1    Analysis by Type
        4.2.2    Analysis by Technology  
5    Global Surrogacy Market (2017-2032) Dynamics
    5.1    Market Drivers and Constraints
    5.2    SWOT Analysis
        5.2.1    Strengths
        5.2.2    Weaknesses
        5.2.3    Opportunities
        5.2.4    Threats
    5.3    Porter’s Five Forces Model
        5.3.1    Bargaining Power of Suppliers
        5.3.2    Bargaining Power of Buyers
        5.3.3    Threat of New Entrants
        5.3.4    Threat of Substitutes
        5.3.5    Degree of Rivalry
    5.4    Key Demand Indicators 
    5.5    Key Price Indicators
    5.6    Industry Events, Initiatives, and Trends  
    5.7    Value Chain Analysis
6    Global Surrogacy Market (2017-2032) Segmentation 
    6.1    Global Surrogacy Market (2017-2032) by Type
        6.1.1    Market Overview 
        6.1.2    Gestational Surrogacy
        6.1.3    Traditional Surrogacy
    6.2    Global Surrogacy Market (2017-2032) by Technology
        6.2.1    Market Overview
        6.2.2    IVF with ICSI
        6.2.3    IVF without ICSI
        6.2.4    Intrauterine Insemination
        6.2.5    Others
    6.3    Global Surrogacy Market (2017-2032) by End User
        6.3.1    Market Overview
        6.3.2    Hospitals
        6.3.3    IVF Centres
        6.3.4    Others
    6.4    Global Surrogacy Market (2017-2032) by Region
        6.4.1    Market Overview
        6.4.2    North America 
        6.4.3    Europe
        6.4.4    Asia Pacific
        6.4.5    Latin America
        6.4.6    Middle East and Africa
7    North America Surrogacy Market (2017-2032)
    7.1    North America Surrogacy Market (2017-2032) by Type
        7.1.1    Market Overview
        7.1.2    Gestational Surrogacy
        7.1.3    Traditional Surrogacy
    7.2    North America Surrogacy Market (2017-2032) by Technology
        7.2.1    Market Overview
        7.2.2    IVF with ICSI
        7.2.3    IVF without ICSI
        7.2.4    Intrauterine Insemination
        7.2.5    Others
    7.3    North America Surrogacy Market (2017-2032) by Country
        7.3.1    United States of America
        7.3.2    Canada
8    Europe Surrogacy Market (2017-2032)
    8.1    Europe Surrogacy Market (2017-2032) by Type
        8.1.1    Market Overview
        8.1.2    Gestational Surrogacy
        8.1.3    Traditional Surrogacy
    8.2    Europe Surrogacy Market (2017-2032) by Technology
        8.2.1    Market Overview
        8.2.2    IVF with ICSI
        8.2.3    IVF without ICSI
        8.2.4    Intrauterine Insemination
        8.2.5    Others
    8.3    Europe Surrogacy Market (2017-2032) by Country
        8.3.1    United Kingdom
        8.3.2    Germany
        8.3.3    France
        8.3.4    Italy
        8.3.5    Others
9    Asia Pacific Surrogacy Market (2017-2032)
    9.1    Asia Pacific Surrogacy Market (2017-2032) by Type
        9.1.1    Market Overview
        9.1.2    Gestational Surrogacy
        9.1.3    Traditional Surrogacy
    9.2    Asia Pacific Surrogacy Market (2017-2032) by Technology
        9.2.1    Market Overview
        9.2.2    IVF with ICSI
        9.2.3    IVF without ICSI
        9.2.4    Intrauterine Insemination
        9.2.5    Others
    9.3    Asia Pacific Surrogacy Market (2017-2032) by Country
        9.3.1    China
        9.3.2    Japan
        9.3.3    India
        9.3.4    Australia
        9.3.5    ASEAN
        9.3.6    Others
10    Latin America Surrogacy Market (2017-2032)
    10.1    Latin America Surrogacy Market (2017-2032) by Type
        10.1.1    Market Overview 
        10.1.2    Gestational Surrogacy
        10.1.3    Traditional Surrogacy
    10.2    Latin America Surrogacy Market (2017-2032) by Technology
        10.2.1    Market Overview
        10.2.2    Gestational Surrogacy
        10.2.3    Traditional Surrogacy
    10.3    Latin America Surrogacy Market (2017-2032) by Country
        10.3.1    Brazil
        10.3.2    Argentina
        10.3.3    Mexico
        10.3.4    Others
11    Middle East and Africa Surrogacy Market (2017-2032)
    11.1    Middle East and Africa Surrogacy Market (2017-2032) by Type
        11.1.1    Market Overview
        11.1.2    Gestational Surrogacy
        11.1.3    Traditional Surrogacy
    11.2    Middle East and Africa Surrogacy Market (2017-2032) by Technology
        11.2.1    Market Overview
        11.2.2    IVF with ICSI
        11.2.3    IVF without ICSI
        11.2.4    Intrauterine Insemination
        11.2.5    Others
    11.3    Middle East and Africa Surrogacy Market (2017-2032) by Country
        11.3.1    Saudi Arabia
        11.3.2    United Arab Emirates
        11.3.3    Nigeria
        11.3.4    South Africa
        11.3.5    Others
12    Patent Analysis
    12.1    Analysis by Type of Patent
    12.2    Analysis by Publication year
    12.3    Analysis by Issuing Authority
    12.4    Analysis by Patent Age
    12.5    Analysis by CPC Analysis
    12.6    Analysis by Patent Valuation 
    12.7    Analysis by Key Players
13    Grants Analysis
    13.1    Analysis by year
    13.2    Analysis by Amount Awarded
    13.3    Analysis by Issuing Authority
    13.4    Analysis by Grant Application
    13.5    Analysis by Funding Institute
    13.6    Analysis by NIH Departments
    13.7    Analysis by Recipient Organization 
14    Funding and Investment Analysis
    14.1    Analysis by Funding Instances
    14.2    Analysis by Type of Funding
    14.3    Analysis by Funding Amount
    14.4    Analysis by Leading Players
    14.5    Analysis by Leading Investors
    14.6    Analysis by Geography
15    Partnership and Collaborations Analysis
    15.1    Analysis by Partnership Instances
    15.2    Analysis by Type of Partnership
    15.3    Analysis by Leading Players
    15.4    Analysis by Geography
16    Regulatory Framework
    16.1    Regulatory Overview
        16.1.1    US FDA
        16.1.2    EU EMA
        16.1.3    INDIA CDSCO
        16.1.4    JAPAN PMDA
        16.1.5    Others
17    Supplier Landscape
    17.1    New Hope Fertility Clinic
        17.1.1    Financial Analysis
        17.1.2    Product Portfolio
        17.1.3    Demographic Reach and Achievements
        17.1.4    Mergers and Acquisitions
        17.1.5    Certifications
    17.2    Houston Fertility Center
        17.2.1    Financial Analysis
        17.2.2    Product Portfolio
        17.2.3    Demographic Reach and Achievements
        17.2.4    Mergers and Acquisitions
        17.2.5    Certifications
    17.3    Ovation Fertility
        17.3.1    Financial Analysis
        17.3.2    Product Portfolio
        17.3.3    Demographic Reach and Achievements
        17.3.4    Mergers and Acquisitions
        17.3.5    Certifications
    17.4    Extraordinary Conceptions
        17.4.1    Financial Analysis
        17.4.2    Financial Portfolio
        17.4.3    Demographic Reach and Achievements
        17.4.4    Mergers and Acquisitions
        17.4.5    Certifications
    17.5    CARE Fertility
        17.5.1    Financial Analysis
        17.5.2    Product Portfolio
        17.5.3    Demographic Reach and Achievements
        17.5.4    Mergers and Acquisitions
        17.5.5    Certifications
    17.6    Growing Generations, LLC
        17.6.1    Financial Analysis
        17.6.2    Product Portfolio
        17.6.3    Demographic Reach and Achievements
        17.6.4    Mergers and Acquisitions
        17.6.5    Certifications
    17.7    IVI RMA GLOBAL
        17.7.1    Financial Analysis
        17.7.2    Product Portfolio
        17.7.3    Demographic Reach and Achievements
        17.7.4    Mergers and Acquisitions
        17.7.5    Certifications
    17.8    CLINIC SCANFERT
        17.8.1    Financial Analysis
        17.8.2    Product Portfolio
        17.8.3    Demographic Reach and Achievements
        17.8.4    Mergers and Acquisitions
        17.8.5    Certifications
    17.9    BOURN HALL FERTILITY CLINIC
        17.9.1    Financial Analysis
        17.9.2    Product Portfolio
        17.9.3    Demographic Reach and Achievements
        17.9.4    Mergers and Acquisitions
        17.9.5    Certifications
    17.10    NOVA IVI FERTILITY
        17.10.1    Financial Analysis
        17.10.2    Product Portfolio
        17.10.3    Demographic Reach and Achievements
        17.10.4    Mergers and Acquisitions
        17.10.5    Certifications
    17.11    Associates Reproductive Medicine & Infertility
        17.11.1    Financial Analysis
        17.11.2    Product Portfolio
        17.11.3    Demographic Reach and Achievements
        17.11.4    Mergers and Acquisitions
        17.11.5    Certifications
    17.12    Cardone
        17.12.1    Financial Analysis
        17.12.2    Product Portfolio
        17.12.3    Demographic Reach and Achievements
        17.12.4    Mergers and Acquisitions
        17.12.5    Certifications
18    Global Surrogacy Market (2017-2032) Distribution Model (Additional Insight)
    18.1    Overview 
    18.2    Potential Distributors 
    18.3    Key Parameters for Distribution Partner Assessment 
19    Key Opinion Leaders (KOL) Insights (Additional Insight)
20    Company Competitiveness Analysis (Additional Insight)

    20.1    Very Small Companies
    20.2    Small Companies
    20.3    Mid-Sized Companies
    20.4    Large Companies
    20.5    Very Large Companies
21    Payment Methods (Additional Insight)
    21.1    Government Funded
    21.2    Private Insurance
    21.3    Out-of-Pocket


*Additional insights provided are customisable as per client requirements.


* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible. 

Key Questions Answered in the Report

The market attained a value of about USD 81.5 billion in 2023, driven by rising infertility problems among people.

The market is anticipated to grow at a CAGR of 24.3% during the forecast period of 2024-2032 and is likely to reach a market value of USD 577.8 billion by 2032.

The market growth is driven by factors such as rising technological advancements in fertility procedures, increasing rates of gamete donations, rising disposable income specifically in developed countries, rising awareness of infertility treatments, and the rise in the prevalence of polycystic ovarian syndrome, companies innovating to bring new technologies into the surrogacy market and increasing collaboration between market players.

Government initiatives such as the Beijing government announcing the inclusion of 16 types of ART technologies under the healthcare system, are among major trends influencing the market growth.

The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East and Africa. North America is currently leading the global market.

Types of surrogacies include gestational surrogacy and traditional surrogacy.

Surrogacy may involve IVF with ICSI, IVF without ICSI, and intrauterine insemination, among others.

End users in the market are hospitals and IVF centres, among others.

Key players involved in the market are New Hope Fertility Clinic, Houston Fertility Center, Ovation Fertility, Extraordinary Conceptions, CARE Fertility, Growing Generations, LLC, IVI RMA GLOBAL, CLINIC SCANFERT, BOURN HALL FERTILITY CLINIC, NOVA IVI FERTILITY, Associates Reproductive Medicine & Infertility, and Cardone.

Purchase Full Report

Mini Report

$ 2969     $2699
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 5499     $4999
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
most popular

Five User License

$ 6599     $5999
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 7699     $6999
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER